Methods of inducing an HIV specific response using a...

Details Methods of inducing an HIV specific response using a... Methods of inducing an HIV specific response using a...

2005-12-13

2005-12-13

Stucker, Jeffrey (Department: 1648)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Fusion protein or fusion polypeptide

C424S185100, C424S188100, C424S196110, C424S202100, C424S208100, C530S350000, C530S328000, C530S826000

Reexamination Certificate

active

06974574

ABSTRACT:
The invention features an immunogenic composition containing a frequently-recognized epitope of an HIV-1 accessory protein such as Vpr and methods of inducing an immune response using such an epitope. The epitope peptide contains the amino acid sequence ALIRILQQL of a functionally active domain or a structural domain of the accessory protein.

REFERENCES:
patent: 6193981 (2001-02-01), Goldstein
patent: 6340461 (2002-01-01), Terman
patent: 6413517 (2002-07-01), Sette et al.
patent: 6534482 (2003-03-01), Fikes et al.
patent: WO 97/34621 (1997-09-01), None
patent: WO 99/58658 (1999-11-01), None
Choppin et al. “HLA-binding regions of HIV-1 proteins. II. A systematic study of viral proteins” Journal of immunology (Baltimore, Md. :1950), vol. 147, No. 2 (Jul. 15, 1991), pp. 575-583.
Sarobe et al. “Induction of neutralizing antibodies against human immunodeficiency virus type 1 using synthetic peptide constructs containing an immunodominant T-helper cell determinant from vpr”, Journal of acquired immune deficiency syndromes, vol. 7, No.
Myers et al. “Human Retroviruses and AIDS, 1991” published by Theoretical Biology and Biophysic Los Alamos National Laboratory, p. II-59.
Addo, et al.,Proc. Natl. Acad. Sci. USA, 98(4):1781-1786 (2001).
Allen, et al.,Nature, 407:386-390 (2000).
Altfeld, et al.,J. Immunol., 167:2743-2752 (2001).
Altfeld, et al.,J. Virol., 75(3):1301-1311 (2001).
Altfeld, et al.,J. Virol., 74(18):8541-8549 (2000).
Altfeld, et al.,J. Exp. Med., 193(2):169-180(2001).
Altfeld, et al.,Curr. Op. Immunol., 12:375-380 (2000).
Borman, et al.,J. Virol., 69(4):2058-2067 (1995).
Boyce, et al.,Virus Genes, 19(1):15-22 (1999).
Brander, et al.,J. Clin. Invest., 101:2559-2566 (1998).
Brander, et al.,Curr. Op. Immunol., 11:451-459 (1999).
Brosterhus, et al.,Eur. J. Immunol., 29(12):4053-4059 (1999).
Bunce, et al.,Tissue Antigens, 45(2):81-90 (1995).
Camaur, et al.,J. Virol., 70(9):6106-6111 (1996).
Chen, et al.,J. Virol., 73(4):3236-3245 (1999).
Cosimi, et al., “The Characterization of HIV-1 Specific CD4+ T Helper Epitopes”, http://hiv-web.lanl.gov/REVIEWS/Cosimi.html, 8 pages.
Cullen, B.R.,Cell, 93(5):685-692 (1998).
Desrosiers, et al.,J. Virol., 72(2):1431-1437 (1998).
DiBrino, et al.,Proc. Natl. Acad. Sci. USA, 90:1508-1512 (1993).
Emerman, et al.,Science, 280:1880-1884 (1998).
Fouchier, et al.,J. Virol., 72(7):6004-6013 (1998).
Fouchier, et al.,Advances in Virus Research, 52:275-299 (1999).
Frankel, et al.,Annu. Rev. Biochem., 67:1-25 (1998).
Gabuzda, et al.,J. Acquir. Immune Defic. Syndr., 7(9):908-915 (1994).
Gabuzda, et al.,J. Virol., 66(11):6489-6495 (1992).
Gibbs, et al.,J. Virol., 69(4):2378-2383 (1995).
Goulder, et al.,J. Virol., 75(3):1339-1347 (2001).
Goulder, et al.,J. Virol., 74(12):5679-5690 (2000).
Goulder, et al.,J. Exp. Med., 185(8):1423-1433 (1997).
Goulder, et al.,J. Exp. Med., 192(12):1819-1831 (2000).
Goulder, et al.,AIDS, 13(suppl. A):S121-S136 (1999).
Goulder, P.J.,Annals of the New York Academy of Sciences, 918:330-345 (2000).
Heinzinger, et al.,Proc. Natl. Acad. Sci. USA, 91:7311-7315 (1994).
Johnson, et al.,J. Immunol., 147(5):1512-1521 (1991).
Kamata, et al.,J. Virol., 74(15):7179-7186 (2000).
Lai, et al.,FEBS Letters, 469:191-195 (2000).
Lang, et al.,J. Virol., 67(2):902-912 (1993).
Mahalingam, et al.,Virology, 207:297-302 (1995).
Mahalingam, et al.,J. Virol., 71(9):6339-6347 (1997).
Marzio, et al.,J. Virol., 69(12):7909-7916 (1995).
McMichael, et al.,Nature, 410:980-987 (2001).
Nie, et al.,J. Virol., 72(5):4104-4115 (1998).
Nietfeld, et al.,J. Immunol., 154(5):2188-2197 (1995).
Nishizawa, et al.,Virology, 263(2):313-322 (1999).
Pitcher, et al.,Nat. Med., 5(5):518-525 (1999).
Plata, et al.,Nature, 328:348-351 (1987).
Poon, et al.,Science, 281:266-269 (1998).
Rammensee, et al.,Immunogenetics, 41(4):178-228 (1995).
Rogel, et al.,J. Virol., 69(2):882-888 (1995).
Rosenberg, et al.,Nature, 407:523-526 (2000).
Sakai, et al.,Virus Genes, 18(2):179-181 (1999).
Scheffold, et al.,Eur. Cytokine Netw., 9(suppl. No. 3):5-11 (1998).
Simon, et al.,J. Virol., 73(4):2675-2681 (1999).
Simon, et al.,J. Virol., 71(7):5259-5267 (1997).
Trono, D.,Cell, 82(2):189-192 (1995).
Trono, D.,Nature, 4(12):1368-1369 (1998).
von Schwedler, et al.,J. Virol., 67(8):4945-4955 (1993).
Walker, et al.,Nature, 407:313-314 (2000).
Walker, et al.,Nature, 328:345-348 (1987).
Walker, et al.,Proc. Natl. Acad. Sci. USA, 86(23):9514-9518 (1989).
Yang, et al.,J. Biol. Chem., 276(7):4889-4893 (2001).
Zhang, et al.,J. Virol., 74(18):8252-8261 (2000).

Affiliated with

Also associated with

Rating

Methods of inducing an HIV specific response using a... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of inducing an HIV specific response using a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of inducing an HIV specific response using a... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3492896